SCHEMBL29514834

SCHEMBL29514834

Cc1c(-c2nc(Nc3ccc(C4CCN(C)CC4)cn3)ncc2F)sc2c(C(C)C)cncc12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CCND1 P24385 16/20 1.00
CDK6 Q00534 13/20 1.00
CDK4 P11802 11/20 0.78
CCND3 P30281 5/20 0.52
CDK2 P24941 4/20 0.52
CCNE2 O96020 3/20 0.52
CCNA2 P20248 4/20 0.51
CCNK O75909 1/20 0.51
CSF1R P07333 1/20 0.51
CDK7 P50613 1/20 0.51
CDK9 P50750 1/20 0.51
CCNH P51946 1/20 0.51
CDK5 Q00535 1/20 0.51
CDK5R1 Q15078 1/20 0.51
CDK1 P06493 3/20 0.50
PIM1 P11309 1/20 0.49
CCNE1 P24864 1/20 0.49
JAK3 P52333 1/20 0.49
MAP3K14 Q99558 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24322218 1.00 CCND1 (1.00) CCND1CDK6CDK4CCND3CDK2
SCHEMBL25237073 0.89 CCND1 (0.85) CCND1CDK6CDK4CCND3CDK2
SCHEMBL25695296 0.88 CCND1 (1.00) CCND1CDK6CDK4CCND3CDK2
SCHEMBL24322142 0.83 CCND1 (0.84) CCND1CDK6CDK4CCND3CDK2
SCHEMBL29514940 0.83 CCND1 (0.84) CCND1CDK6CDK4CCND3CDK2
SCHEMBL25284628 0.83 CCND1 (0.70) CCND1CDK6CDK4CCND3CDK2
SCHEMBL29515094 0.81 CCND1 (0.78) CCND1CDK6CDK4CCND3CDK2
SCHEMBL29514902 0.80 CCND1 (0.80) CCND1CDK6CDK4CCND3CDK2
SCHEMBL25242810 0.78 CCND1 (0.79) CCND1CDK6CDK4CCND3CDK2
SCHEMBL24322346 0.78 CCND1 (1.00) CCND1CDK6CDK4CCND3CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4214213-A1 CDK INHIBITORS AND THEIR USE AS PHARMACEUTICALS Prelude Therapeutics, Incorporated (US) 2023-07-26 EP claimed
WO-2022061273-A1 CDK INHIBITORS AND THEIR USE AS PHARMACEUTICALS PRELUDE THERAPEUTICS, INCORPORATED (US) 2022-03-24 WO claimed
EP-4214213-A1 CDK INHIBITORS AND THEIR USE AS PHARMACEUTICALS Prelude Therapeutics, Incorporated (US) 2023-07-26 EP disclosed
WO-2022061273-A1 CDK INHIBITORS AND THEIR USE AS PHARMACEUTICALS PRELUDE THERAPEUTICS, INCORPORATED (US) 2022-03-24 WO disclosed